These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chloroquine-induced neuromyopathy. Report of a case. Parodi A; Regesta G; Rebora A Dermatologica; 1985; 171(3):203-5. PubMed ID: 4076494 [TBL] [Abstract][Full Text] [Related]
3. Amiodarone-associated neuromyopathy: a report of four cases. Flanagan EP; Harper CM; St Louis EK; Silber MH; Josephs KA Eur J Neurol; 2012 May; 19(5):e50-1. PubMed ID: 22507462 [No Abstract] [Full Text] [Related]
4. Canalicular cholestasis due to amiodarone toxicity. A definite diagnosis obtained by electron microscopy. Macarri G; Feliciangeli G; Berdini V; Jezequel AM; Benedetti A Ital J Gastroenterol; 1995; 27(8):436-8. PubMed ID: 8775470 [TBL] [Abstract][Full Text] [Related]
5. A case of amiodarone and neuromyopathy. Silva Oropeza E; Peralta Rosado HR; Valero Elizondo C; Sadowinski E; Magaña Serrano JA Rev Invest Clin; 1997; 49(2):135-9. PubMed ID: 9294958 [TBL] [Abstract][Full Text] [Related]
6. Amiodarone-induced neuromyopathy in a geriatric patient. Stanton MM; Samii L; Leung G; Pearce P BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148598 [TBL] [Abstract][Full Text] [Related]
7. SIADH induced by amiodarone in a patient with heart failure. Paydas S; Araz F; Balal M Int J Clin Pract; 2008 Feb; 62(2):337. PubMed ID: 18199281 [No Abstract] [Full Text] [Related]
8. [What is your diagnosis? Pseudocyanosis due to amiodarone]. Sendi P; Itin P Praxis (Bern 1994); 2004 Oct; 93(42):1725-6. PubMed ID: 15529959 [No Abstract] [Full Text] [Related]
9. Amiodarone-induced skin pigmentation: Q-switched laser therapy, an effective treatment option. Wiper A; Roberts DH; Schmitt M Heart; 2007 Jan; 93(1):15. PubMed ID: 17170336 [No Abstract] [Full Text] [Related]
10. Amiodarone-induced lung disease. Emby DJ S Afr Med J; 2008 Jan; 98(1):9. PubMed ID: 18270625 [No Abstract] [Full Text] [Related]
12. Hypomelanosis due to block of melanosomal maturation in amiodarone-induced hyperpigmentation. Haas N; Schadendorf D; Hermes B; Henz BM Arch Dermatol; 2001 Apr; 137(4):513-4. PubMed ID: 11295949 [No Abstract] [Full Text] [Related]
13. Delayed development of amiodarone keratopathy in a corneal graft. Davitt SP; Mannis MJ Cornea; 1997 Nov; 16(6):695-7. PubMed ID: 9395883 [No Abstract] [Full Text] [Related]
14. Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodarone. Blomberg PJ; Feingold AD; Denofrio D; Rand W; Konstam MA; Estes NA; Link MS Am J Cardiol; 2004 Feb; 93(3):379-81. PubMed ID: 14759399 [TBL] [Abstract][Full Text] [Related]
15. Disabling neurological complications of amiodarone. Anderson NE; Lynch NM; O'Brien KP Aust N Z J Med; 1985 Jun; 15(3):300-4. PubMed ID: 3864421 [TBL] [Abstract][Full Text] [Related]
16. Amiodarone and the lung: wide variations in clinical practice. Cox G; Johnson J; Kinnear WJ; Johnston ID Respir Med; 2000 Nov; 94(11):1130-1. PubMed ID: 11127503 [No Abstract] [Full Text] [Related]
18. [Utility of personalized intensive multifactorial neurorehabilitation in two patients with toxic polyneuropathy (amiodarone and arsenic) and in one with polymyositis]. Calzada-Sierra DJ Rev Neurol; 2001 Apr 1-15; 32(7):697-9. PubMed ID: 16121412 [No Abstract] [Full Text] [Related]
19. [Amiodarone neuropathy]. Kaeser HE Schweiz Med Wochenschr; 1974 Apr; 104(17):606-8. PubMed ID: 4827766 [No Abstract] [Full Text] [Related]
20. An unusual manifestation of amiodarone toxicity: lung mass mimicking a lung carcinoma. Liyanage UA; Rajapakse T; Somaratne SC; Gunaratne PS Ceylon Med J; 2011 Jun; 56(2):74-6. PubMed ID: 21789872 [No Abstract] [Full Text] [Related] [Next] [New Search]